Lachnoclostridium edouardi

Information

Microbe Identification

Lachnoclostridium edouardi

Microbe id: PMDBM2021570
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Lachnoclostridium edouardi [1926283]
Taxonomy Genus: Lachnoclostridium [1506553]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Lachnoclostridium edouardi

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Lachnoclostridium edouardi


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Lachnoclostridium edouardi distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Lachnoclostridium edouardi in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Lachnoclostridium edouardi

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA648014🔗-3.9053499486001316S
Kidney Failure, Chronic PRJEB65297🔗3.22306030351685mNGS
Kidney Failure, Chronic PRJNA449784🔗3.22812056434363mNGS
Hypertension PRJNA509999🔗2.91730021312647mNGS
Depression, Postpartum PRJNA637228🔗-3.3229938598634416S
Arthritis, Juvenile PRJNA562467🔗4.1710152674169516S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-3.7856658373822116S
Colorectal Neoplasms PRJNA763023🔗2.98485588686979mNGS
Colorectal Neoplasms PRJNA936589🔗2.98985642226124mNGS
Colorectal Neoplasms PRJNA888860🔗3.04899270539066mNGS
Colorectal Neoplasms PRJNA731589🔗3.19289370001472mNGS
Colorectal Neoplasms PRJNA1138893🔗3.20987918048276mNGS
Diabetes Mellitus, Type 1 PRJNA893406🔗2.6933090793191mNGS
Mental Disorders PRJNA278793🔗-3.8451139523269416S
Hepatitis, Autoimmune PRJNA556801🔗4.3259772084253916S
Parkinson Disease PRJNA742875🔗-3.5699917440799216S
Colitis, Ulcerative PRJNA993675🔗-3.26732965863635mNGS
Colitis, Ulcerative PRJNA813736🔗2.1607558254063mNGS
Colitis, Ulcerative PRJNA398089🔗2.68624953787756mNGS
Campylobacter Infections PRJNA660443🔗3.85150218072625mNGS
Spinal Cord Injuries PRJNA669472🔗-3.4971929146221316S
Spinal Cord Injuries PRJNA861246🔗3.1040357902280816S
Hepatitis B, Chronic PRJNA872871🔗-3.9649699406442116S
Carcinoma, Renal Cell PRJNA842560🔗-3.7238599864044416S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.5607955302376616S
Leukemia, Myeloid, Acute PRJNA813705🔗2.66709445286283mNGS
Crohn Disease PRJNA1156939🔗-4.0308831149298716S
Crohn Disease PRJNA820056🔗-2.1847336696004316S
Crohn Disease PRJNA398089🔗2.5820512187365mNGS
Crohn Disease PRJNA813736🔗2.99931620985361mNGS
Crohn Disease PRJNA993675🔗3.43428648470104mNGS
Crohn Disease PRJNA938107🔗3.8228589434535616S
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗-3.5501207882614716S
Moyamoya Disease PRJNA917033🔗3.7369720722183116S
Arthritis, Rheumatoid PRJNA896336🔗3.24265895089405mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗2.721883012835mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗2.92939058368664mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗2.95314847676839mNGS
Anorexia PRJNA674716🔗3.38545219573581mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗4.7863485340049916S
Nephrotic Syndrome PRJNA800189🔗4.5395856799768216S
Flatulence PRJNA206071🔗3.4348653418999716S
Anorexia Nervosa PRJEB11199🔗-3.2723254666557616S
Hepatitis C PRJNA1070593🔗-3.7318088499669216S
Neuroblastoma PRJEB63351🔗3.56392655195699mNGS
Hematologic Neoplasms PRJNA777832🔗2.9636972800679916S
Irritable Bowel Syndrome PRJEB37924🔗2.69385741228466mNGS
Irritable Bowel Syndrome PRJNA705217🔗3.38255627450302mNGS
Schistosomiasis japonica PRJNA625383🔗-3.562836704294716S
Lung Neoplasms PRJNA507734🔗-3.655257946238216S
Glomerulonephritis, IGA PRJNA785415🔗-3.893395813787416S
Liver Cirrhosis PRJNA872871🔗-4.0649466119383316S
Liver Cirrhosis PRJNA861246🔗3.2339280496674316S
Cystic Fibrosis PRJNA314903🔗3.59233240459133mNGS
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗-3.7650706973656916S
Obesity PRJNA1125836🔗2.79438588235753mNGS
HIV Infections PRJNA810567🔗-3.8537224766743416S
Autism Spectrum Disorder PRJNA1037036🔗2.93837759771627mNGS
Autism Spectrum Disorder PRJNA686821🔗3.28327690623115mNGS
Retinal Artery Occlusion PRJEB24557🔗-2.68812273106176mNGS
Neuromyelitis Optica PRJNA662563🔗3.1067685431400716S
Inflammatory Bowel Diseases PRJEB13266🔗-3.4317973971748916S
Biliary Atresia PRJNA730640🔗-3.39285908753293mNGS
Renal Insufficiency, Chronic PRJNA949558🔗-4.0736590971516316S
Renal Insufficiency, Chronic PRJNA772031🔗-4.0624507987360816S
Renal Insufficiency, Chronic PRJNA659589🔗-3.5750752105086816S
Renal Insufficiency, Chronic PRJNA562327🔗-3.410391379106116S
Renal Insufficiency, Chronic PRJEB65297🔗2.95066180835082mNGS
Multiple Sclerosis PRJEB28543🔗3.2064598145753mNGS
Fibromyalgia PRJNA521587🔗2.57145415106129mNGS
Breast Neoplasms PRJNA658160🔗3.1968979948193416S
COVID-19 PRJNA769052🔗-3.2421945417592516S
COVID-19 PRJDB13214🔗3.55864652751244mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Lachnoclostridium edouardi



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Lachnoclostridium edouardi



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Lachnoclostridium edouardi

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Lachnoclostridium edouardi


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Lachnoclostridium edouardi



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Lachnoclostridium edouardi

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Lachnoclostridium edouardi

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Lachnoclostridium edouardi

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Lachnoclostridium edouardi



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Lachnoclostridium edouardi


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Lachnoclostridium edouardi


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?